Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
Stockholm, Sweden: Men with prostate cancer that has spread to other parts of the body and that is resistant to hormone therapy suffer less from fatigue if they are treated with a combination of abiraterone acetate and prednisone, ...
Sep 25, 2011
0
0